Background: Rhinoviruses (RVs) are a major cause of common colds and induce exacerbations of asthma and chronic inflammatory lung diseases.
Methods: We expressed and purified recombinant RV coat proteins VP1-4, non-structural proteins as well as N-terminal fragments of VP1 from four RV strains (RV14, 16, 89, C) covering the three known RV groups (RV-A, RV-B and RV-C) and measured specific IgG-subclass-, IgA- and IgM-responses by ELISA in subjects with different severities of asthma or without asthma before and after experimental infection with RV16.
Findings: Before infection subjects showed IgG1 > IgA > IgM > IgG3 cross-reactivity with N-terminal fragments from the representative VP1 proteins of the three RV groups. Antibody levels were higher in the asthmatic group as compared to the non-asthmatic subjects. Six weeks after infection with RV16, IgG1 antibodies showed a group-specific increase towards the N-terminal VP1 fragment, but not towards other capsid and non-structural proteins, which was highest in subjects with severe upper and lower respiratory symptoms.
Interpretation: Our results demonstrate that increases of antibodies towards the VP1 N-terminus are group-specific and associated with severity of respiratory symptoms and suggest that it may be possible to develop serological tests for identifying causative RV groups.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484518 | PMC |
| http://dx.doi.org/10.1016/j.ebiom.2014.11.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Expression of bluetongue virus full-length VP7 protein in insect cells and its diagnostic utility for detection of antibodies to the virus infection.
J Immunol Methods
January 2025
ICAR-Indian Veterinary Research Institute, Bangalore, Karnataka 560024, India.
Bluetongue (BT) is a vector-borne viral disease of multiple domestic and wild ruminants across the globe. The VP7 protein of bluetongue virus (BTV) is the major immune-dominant structural protein that is conserved across the BTV serotypes and therefore, targeted for the development of immuno-diagnostics for BT. In this study, full-length recombinant VP7 protein (rVP7) of BTV-1 was expressed in Trochoplusia ni derived insect cells (Tn5) using codon-optimized synthetic gene construct through baculovirus expression system.
View Article and Find Full Text PDFChallenges of BTV-Group Specific Serology Testing: No One Test Fits All.
Viruses
November 2024
The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Animal Health Laboratory, Australian Centre for Disease Preparedness, 5 Portarlington Road, East Geelong, VIC 3219, Australia.
A newly formatted enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to bluetongue virus (BTV) was developed and validated for bovine and ovine sera and plasma. Validation of the new sandwich ELISA (sELISA) was achieved with 949 negative bovine and ovine sera from BTV endemic and non-endemic areas of Australia and 752 BTV positive (field and experimental) sera verified by VNT and/or PCR. The test diagnostic sensitivity (DSe) and diagnostic specificity (DSp) were 99.
View Article and Find Full Text PDFIdentification of three novel linear B-cell epitopes on VP7 of African horse sickness virus using monoclonal antibodies.
Vet Microbiol
November 2024
State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730000, China; Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou 730046, China. Electronic address:
Article Synopsis
- * The research involved creating a recombinant version of the VP7 protein in E. coli and identifying four monoclonal antibodies that recognize specific B-cell epitopes on this protein through various immunological methods.
- * Findings revealed conserved epitopes among different AHSV serotypes, which could aid in developing better diagnostic tools and potential vaccine strategies against AHS.
Dynamic establishment and maintenance of the human intestinal B cell population and repertoire following transplantation in a pediatric-dominated cohort.
Front Immunol
July 2024
Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Article Synopsis
- The study investigates how B cell populations and their receptors evolve in the intestines of humans, particularly after intestinal transplantation, using biopsies for observation.
- Researchers employed advanced techniques like polychromatic flow cytometry and B cell receptor sequencing to differentiate between donor and recipient B cells and assess their development in the transplanted intestines.
- Findings reveal that recipient B cells, including memory B cells, rapidly populate the transplanted intestines mainly in infants, and their B cell receptors evolve differently in the graft compared to circulation, with notable clonal mixing remaining years after the transplant.
A Highly Sensitive and Group-Specific Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of AFB in Agriculture and Aquiculture Products.
Molecules
May 2024
The Key Lab of Health Chemistry and Molecular Diagnosis of Suzhou, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Renai Road 199, Suzhou 215123, China.
Aflatoxins (AFs) including AFB, AFB, AFG and AFG are widely found in agriculture products, and AFB is considered one of the most toxic and harmful mycotoxins. Herein, a highly sensitive (at the pg mL level) and group-specific enzyme-linked immunosorbent assay (ELISA) for the detection of AFB in agricultural and aquiculture products was developed. The AFB derivative containing a carboxylic group was synthesized and covalently linked to bovine serum albumin (BSA).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!